Danimer Scientific — Q3 2021 Earnings Presentation
13 slides from Danimer Scientific's earnings presentation, Nov 15, 2021
Slide 1: Third Quarter 2021 Earnings Presentation
Third Quarter 2021 Earnings Presentation November 15, 2021
Slide 2: Disclaimer
Disclaimer This presentation (“Presentation”) is for informational purposes only. This Presentation shall not constitute an offer to sell, or the solicitation of an offer to buy, any securities, nor shall there be any sale of securities in any states or jurisdictions in which such offer, solicitatio
Slide 3: Business Highlights
Business Highlights Business Highlights Continued execution of growth strategy to transform the bioplastics market Closed on Novomer acquisition and made progress with integration Received grant to expand research of soybean oil uses in production Partnered with Chevron Phillips to develop tech for
Slide 4: Blue Chip Customers Select Danimer to Help Fulfill their ESG Commitments
Blue Chip Customers Select Danimer to Help Fulfill their ESG Commitments 4
Slide 5: Kentucky Phase II Expansion: Fermentation Chiller Building Update
Kentucky Phase II Expansion: Fermentation Chiller Building Update Greenfield Part 2 Nameplate capacity 125MM lbs.(1) 5 6 7 8 9 10 Kentucky Phase II Fermentation Chiller Building Kentucky Phase II Fermentation Chiller Building Pre Construction (December 2020) Construction Progress (November 2021) Ken
Slide 6: Kentucky Phase II Expansion: Downstream Processing Facility Update
Kentucky Phase II Expansion: Downstream Processing Facility Update 9 10 Kentucky Phase II Downstream Processing Kentucky Phase II: Nameplate capacity of 45MM lbs of finished product expected to be completed in Q2 2022 Pre Construction (December 2020) Construction Progress (November 2021) Kentucky Ph
Slide 7: Kentucky Phase II Expansion: Extrusion Facility Update
Kentucky Phase II Expansion: Extrusion Facility Update 5 6 7 8 9 10 Kentucky Phase II Extrusion Facility Pre Construction (December 2020) Construction Progress (November 2021) Kentucky Phase II Extrusion Facility Kentucky Phase II: Nameplate capacity of 45MM lbs of finished product expected to be co
Slide 8: Q3 2021 Financial Summary
Q3 2021 Financial Summary PHA increased to 32% of revenue vs 12% in Q3 2020 Costs influenced by: Elevated fixed-cost absorption at our Kentucky Facility as we scale up production Investments in headcount and salaries to support future expansion plans Public company costs Novomer acquisition costs Ke
Slide 9: Modeling Assumptions for 2021
Modeling Assumptions for 2021 Volumes: Phase I production expected to scale to 100% by year end Phase I turnaround completed in 2Q’21 to debottleneck and accelerate scale-up Phase II production expected to commence in 2Q’22 Operating Costs: Total SG&A and R&D costs expected to be $31mm for the year,
Slide 10: Danimer is a Next Generation Bioplastics Company
Danimer is a Next Generation Bioplastics Company ` Experienced Leadership Team and Board of Directors with Proven Track Record 6 Significant Tailwinds From Increased Corporate and Legislative Initiatives on Environmental Impact of Global Pollution Crisis 2 Highly Attractive PHA Technology Serves as
Slide 11: Danimer Scientific
4 danimer ~ scientific
Slide 12: EBITDA and EBITDAR Reconciliation
EBITDA and EBITDAR Reconciliation Note: 1 - Totals may not foot due to rounding.
Slide 13: Adjusted Gross Profit Reconciliation
Adjusted Gross Profit Reconciliation Note: 1 - Totals may not foot due to rounding.